OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Efficiency of application of sorbed probiotics in complex therapy of pneumonia caused by SARS-CoV-2. Part 1. Heating clinical displays period
Е. Р. Мескина, Е. Е. Целипанова, M. K. Khadisova, et al.
Terapevticheskii arkhiv (2021) Vol. 93, Iss. 4, pp. 456-464
Open Access | Times Cited: 11

Showing 11 citing articles:

Probiotics improve symptoms of patients with COVID-19 through gut-lung axis: a systematic review and meta-analysis
Yong Tian, Hongmei Ran, Xudong Wen, et al.
Frontiers in Nutrition (2023) Vol. 10
Open Access | Times Cited: 17

Safety and efficacy of probiotic supplements as adjunctive therapies in patients with COVID-19: A systematic review and meta-analysis
Julie Zhu, Tyler Pitre, Carmen Ching, et al.
PLoS ONE (2023) Vol. 18, Iss. 3, pp. e0278356-e0278356
Open Access | Times Cited: 12

Retracted: Gut microbiota and COVID‐19: A systematic review
SeyedAhmad SeyedAlinaghi, Arian Afzalian, Zahra Pashaei, et al.
Health Science Reports (2023) Vol. 6, Iss. 2
Open Access | Times Cited: 9

Benefits of probiotic use on COVID-19: A systematic review and meta-analysis
Suelen Neris Almeida Viana, Tamires do Reis Santos Pereira, Janaína de Carvalho Alves, et al.
Critical Reviews in Food Science and Nutrition (2022) Vol. 64, Iss. 10, pp. 2986-2998
Closed Access | Times Cited: 13

Clinical efficacy of probiotics in the treatment of patients with COVID-19: A systematic review and meta-analysis of randomized controlled trials
Jheng‐Yan Wu, Po‐Yu Huang, Tinghui Liu, et al.
Expert Review of Anti-infective Therapy (2023) Vol. 21, Iss. 6, pp. 667-674
Closed Access | Times Cited: 5

Overview of anti-viral effects of probiotics via immune cells in pre-, mid- and post-SARS-CoV2 era
Osamu Kanauchi, Zhao Xuan Low, Kenta Jounai, et al.
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 3

Bifidobacteria in disease: from head to toe
Weiliang Zhang, Qiang Jia, Mingming Han, et al.
Folia Microbiologica (2023) Vol. 69, Iss. 1, pp. 1-15
Closed Access | Times Cited: 2

Probiotics in prevention and treatment of COVID-19: a systematic review of current evidence
SeyedAhmad SeyedAlinaghi, Ramin Shahidi, Arian Afzalian, et al.
Russian Journal of Infection and Immunity (2023) Vol. 13, Iss. 4, pp. 709-722
Open Access | Times Cited: 1

Probiotics in treatment of respiratory viral infections
Н. В. Барышникова
Medical alphabet (2023), Iss. 11, pp. 6-12
Closed Access

The Role of Gut Microbiome Supplementation in COVID-19 Management
Mc Anto Antony, Siddharth Patel, Vipin Kumar Verma, et al.
Cureus (2023)
Open Access

Efficiency of application of sorbed probiotics in the complex therapy of pneumonia caused by SARS-CoV-2. Quality of life in the short term COVID-19
Е. Р. Мескина, M. K. Khadisova, T.V. Stashko, et al.
Infectious diseases News Opinions Training (2022) Vol. 11, Iss. 3, pp. 69-80
Open Access

Page 1

Scroll to top